In type 2 diabetes, the development of hyperglycaemia is facilitated by pancreatic β-cell dysfunction, including a reduced incretin effect, which is defined as the relative increase in insulin secretion induced by oral versus intravenous glucose administration. Here, INS is linked to Hyperglycemia.